Czech Approval Process

Czech Republic has been a EU member since 2004 and its legislation has been almost fully harmonized with the EU including the Drug Law.
Clinical study start-up time: 4.5 months.

Czech Republic Recruitment Potential

Czech Republic is currently one of the most prevailing on the clinical trial markets thanks to its good compliance to ICH-GCP guidelines, and the presence of highly qualified clinical investigators. Czech Republic offers a good environment to perform clinical trials.
Over the last two years, in Belarus about 180 studies were conducted mainly focusing on oncology, cardiology and diabetes.

Investigators and Sites

Czech Republic hosts more than 800 sites including public and private hospitals and clinics, fully equipped and offering the highest standard of treatment and diagnostic procedures. Investigators are ICH GCP experienced, well-educated with most of the Czech staff having scientific background, which leads to excellent relations with the investigators and high quality of data.